Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)
Clinical trial NCT00945438 · COMPLETED
Trial details
- NCT number
- NCT00945438
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2009-06-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.